<SEC-DOCUMENT>0001683168-20-002615.txt : 20200811
<SEC-HEADER>0001683168-20-002615.hdr.sgml : 20200811
<ACCEPTANCE-DATETIME>20200810215817
ACCESSION NUMBER:		0001683168-20-002615
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20200810
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200811
DATE AS OF CHANGE:		20200810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		201090950

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>radnet_i8k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:RDNT="http://radnet.com/20200810">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_RDNT_radnet.com_20200810 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20200810_20200810 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-08-10to2020-08-10" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-08-10to2020-08-10" id="xdx2ixbrl0010" name="dei:DocumentPeriodEndDate">2020-08-10</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="rdnt-20200810.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-08-10to2020-08-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-10</xbrli:startDate>
        <xbrli:endDate>2020-08-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 3pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>UNITED
STATES</b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>______________________________&#160;</b></p>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>FORM <span id="xdx_90F_edei--DocumentType_c20200810__20200810_zTgLxKCuSD2j"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>______________________________&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported
<span id="xdx_901_edei--DocumentPeriodEndDate_c20200810__20200810_zo6u0ZvZQAf5"><span style="-sec-ix-hidden: xdx2ixbrl0010">August 10, 2020)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<p style="font: 24pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 14pt"><b><span id="xdx_90A_edei--EntityRegistrantName_c20200810__20200810_zLuutwaEJrj"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:EntityRegistrantName">RADNET,
Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>______________________________&#160;</b></p>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 32%; text-align: center"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20200810__20200810_zoRMQJdvFiy8"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 32%; text-align: center"><span id="xdx_90C_edei--EntityFileNumber_c20200810__20200810_zZ2WYkFccAdc"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:EntityFileNumber">001-33307</ix:nonNumeric></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 32%; text-align: center"><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20200810__20200810_zvGaYhYSRpzb"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:EntityTaxIdentificationNumber">13-3326724</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(State or Other Jurisdiction of Incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(IRS Employer Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: normal"><span id="xdx_905_edei--EntityAddressAddressLine1_c20200810__20200810_zE9Jm6RqI5Ah"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:EntityAddressAddressLine1">1510 Cotner
Avenue</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: normal"><span id="xdx_90C_edei--EntityAddressCityOrTown_c20200810__20200810_z7k19uJyK4b"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span>,
<span id="xdx_905_edei--EntityAddressStateOrProvince_c20200810__20200810_zNGWQyHTHqZ"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20200810__20200810_zg2x8LGoC7V6"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:EntityAddressPostalZipCode">90025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: normal"><span style="font-size: 10pt">(Address of Principal Executive Offices) (Zip Code)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90B_edei--CityAreaCode_c20200810__20200810_zsSci9y6IpN7"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:CityAreaCode">(310)</ix:nonNumeric></span>&#160;<span id="xdx_903_edei--LocalPhoneNumber_c20200810__20200810_z2sDv8HYyDel"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:LocalPhoneNumber">478-7808</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">(Registrant&#8217;s Telephone Number, Including Area Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_908_edei--WrittenCommunications_c20200810__20200810_zwDuijrZPGt2"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span> &#160;&#160;&#160;Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_907_edei--SolicitingMaterial_c20200810__20200810_zYFSHeFBGPel"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span> &#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_906_edei--PreCommencementTenderOffer_c20200810__20200810_ziGQVyJu3zpd"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span> &#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b) )</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20200810__20200810_z8e7u00YOFbh"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span>&#160;&#160;&#160; Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c) )</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="background-color: white">Securities registered
pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Class
    Title</span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 32%; text-align: center"> <span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Trading Symbol</span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 32%; text-align: center"> <span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Registered Exchange</span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span id="xdx_906_edei--Security12bTitle_c20200810__20200810_zIZ3u9geXfAe"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span id="xdx_909_edei--TradingSymbol_c20200810__20200810_zxhd6Q8jgXd2"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" name="dei:TradingSymbol">RDNT</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span id="xdx_900_edei--SecurityExchangeName_c20200810__20200810_zczGmwcZFfj"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span></td></tr>
</table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2
of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">Emerging growth
company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20200810__20200810_zFOTtU0EPOH2"><ix:nonNumeric contextRef="From2020-08-10to2020-08-10" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 3pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in">Item 2.02</td><td>RESULTS OF OPERATIONS AND FINANCIAL CONDITION</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 10, 2020
RadNet, Inc. (&#8220;RadNet&#8221;) issued a press release and held a conference call regarding our 2020 financial results for
the second quarter ended June 30, 2020. A copy of the press release is furnished as Exhibit 99.1 and a copy of the transcript of
the conference call is furnished as Exhibit 99.2 to this Current Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in
this Current Report, including Exhibit 99.1 and Exhibit 99.2 is being furnished and shall not be deemed &#8220;filed&#8221; for
purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information
in this Current Report, including Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference into any registration statement
or other document filed with the Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 9.01</b></td><td style="text-align: justify"><b>FINANCIAL STATEMENTS AND EXHIBITS.</b></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt; width: 15%"><span style="font-weight: normal"><span style="text-decoration: underline">Exhibit Number</span></span></td>
    <td style="padding-left: 10pt; text-indent: -10pt; width: 85%"><span style="font-weight: normal"><span style="text-decoration: underline">Description of Exhibit</span></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">99.1</td>
    <td style="padding-left: 10pt; text-indent: -10pt">
<a href="radnet_ex9901.htm">Press Release dated August 10, 2020 relating to RadNet, Inc.&#8217;s financial results for the quarter ended June 30, 2020.</a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">99.2</td>
    <td style="padding-left: 10pt; text-indent: -10pt"><a href="radnet_ex9902.htm">Transcript of conference call.</a></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: -2.5in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">SIGNATURE</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 29%">Date:&#160;&#160;&#160;August 11, 2020</td>
    <td style="width: 71%; padding-left: 0.3in; text-indent: 1.2in"><b>RADNET, INC.</b></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">By: <span style="text-decoration: underline">/s/ Mark D. Stolper&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Name: Mark D. Stolper<br />
        Title: Chief Financial Officer</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in">&#160;</p></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT INDEX</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt; width: 15%"><b><span style="text-decoration: underline">Exhibit No.</span></b></td>
    <td style="padding-left: 10pt; text-indent: -10pt; width: 85%"><b><span style="text-decoration: underline">Description</span></b></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">99.1</td>
    <td style="padding-left: 10pt; text-indent: -10pt">
<a href="radnet_ex9901.htm"><b>Press Release dated August 10, 2020</b></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">99.2</td>
    <td style="padding-left: 10pt; text-indent: -10pt"><b><a href="radnet_ex9902.htm">Transcript of conference call.</a></b></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: -2.5in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PbQbKrJLhw5xyhgi3haXSXFrRlp/9ki+pXVDDIGQnPPlCBGKjDa6QYbzqszhiG3XKIdQYo2M5oLekW53CfhZ4lVbx8q4Yf2BKXkGPTOfzJS/D86HtlglIJfTSE5jCXKRzCMo9iL46imZWldonFYNKFNBwdSxRqe4Hz8c1YsMtf2QdEK2mkwC0USO8htiGcVwoId6Et8s5HkqgnCoQGRM9+4bc7eOWlg32PosO6L/Dj7caUkX -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>radnet_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: red"><B><IMG SRC="image_001.jpg" ALT="RadNet Logo JPEG  - no tag line" STYLE="height: 99px; width: 230px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR IMMEDIATE RELEASE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 12pt"><B>RadNet Reports Second Quarter
Financial Results</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>As a result of taking immediate expense and cash savings measures
to react to the impact of COVID-19 on patient volume, RadNet finished the quarter with a cash balance exceeding $84 million and
was undrawn on its $137.5 million revolving line of credit</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>RadNet has re-opened 77 of the 102 facilities temporarily closed
because of COVID-19</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Procedural volumes have returned to approximately 90% of pre-COVID-19
per day volumes, from a low point in mid-April of 28% of pre-COVID-19 per day volumes</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>For the quarter, and as a result of COVID-19, Revenue decreased
34.1% to $190.6 million in the second quarter of 2020 from $289.1 million in the second quarter of 2019</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Adjusted EBITDA<SUP>(1)</SUP> decreased 47.6% to $22.6 million
in the second quarter of 2020 from $43.1 million in the second quarter of 2019 </I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Adjusted diluted loss per share was $(0.16) in the second quarter
of 2020, as adjusted on a tax-effected basis for the non-cash change in the fair value of an interest rate hedge, as compared with
diluted earnings per share of $0.10 from the prior year&rsquo;s second quarter </I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Aggregate procedural volumes decreased 43.7% and same-center procedural
volumes decreased 43.4% from the second quarter of 2019</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Subsequent to quarter end, RadNet and Hologic, Inc. announced a
comprehensive collaboration to improve breast cancer care, including the co-development of Artificial Intelligence tools, data-sharing
and an upgrade of RadNet&rsquo;s fleet of Hologic mammography units to cutting-edge technology</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LOS ANGELES, California, August 10,
2020 &ndash; RadNet, Inc. (NASDAQ: RDNT),</B> <FONT STYLE="color: black">a national leader in providing high-quality, cost-effective,
fixed-site outpatient diagnostic imaging services through a network of 332 owned and/or operated outpatient imaging centers</FONT>,
today reported financial results for its second quarter of 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief
Executive Officer of RadNet, commented, &ldquo;I am extremely pleased with the recovery we are experiencing relative to the low
point of our procedural volumes during this COVID-19 period. Our procedural volumes reached a low point during the second week
of April, at roughly 28% of the pre-COVID-19 per day averages of January and February. Currently, we are close to 90% of our pre-COVID
per day volumes and are optimistic about further recovery as the year progresses.&rdquo;</P>

<P STYLE="color: red; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger continued, &ldquo;Our operations
teams and executive management moved with great urgency in March to aggressively take the actions necessary to lower our costs
and conserve cash under very extreme health and social conditions and substantially reduced patient volume. The actions we took,
which included temporarily closing facilities, consolidating patient volume into the centers of excellence which remained open,
negotiating and restructuring agreements with vendors and landlords and reducing employee costs through furloughs and temporary
salary cuts, among other actions, proved to secure our business in this difficult period. I want to thank the employees of RadNet,
who are meeting the challenges during these difficult times and who are making great personal sacrifices for the benefit of our
Company, our referring physicians, and most importantly, our patients.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;We will continue to evaluate the
re-opening of locations and bring back furloughed employees as our business further recovers. Currently, 25 of our 332 facilities
remain closed. During the COVID-19 period, we were assisted by approximately $25.5 million in grants we received under the CARES
Act Provider Relief Fund and approximately $44.4 million we received in the form of advances from the Centers for Medicare and
Medicaid Services and one west coast insurance company. Despite having to repay these advances during the second half of this year,
we expect that our business will add to the $84.6 million cash balance we had at quarter end,&rdquo; added Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger concluded, &ldquo;Notwithstanding
this difficult operating environment, we remain committed to executing our strategic objectives. Last week, we announced a collaboration
agreement with Hologic, Inc. focused on improving breast health and advancing both companies&rsquo; objectives around Artificial
Intelligence (A.I.). The multifaceted agreement incorporates data sharing, co-development of R&amp;D, collaboration on A.I. algorithms,
joint market opportunities and the upgrade of RadNet&rsquo;s fleet of Hologic mammography units to state-of-the art imaging technology.
This collaboration with Hologic furthers RadNet&rsquo;s commitment to developing A.I. solutions that will transform radiology
and improve radiologist accuracy and patient care. We remain on track with our DeepHealth division&rsquo;s plan to submit for
U.S. Food and Drug Administration review its first A.I. product later this year. In addition to this, we continue to pursue accretive
strategic acquisitions of targets whose operations have been impacted as a result of the COVID-19 market conditions. We look forward
to providing updates on these activities in the near future.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Second Quarter Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter of 2020, RadNet
reported Revenue of $190.6 million and Adjusted EBITDA<SUP>(1)</SUP> of $22.6 million. Revenue decreased $98.5 million (or 34.1%)
and Adjusted EBITDA<SUP>(1)</SUP> decreased $20.5 million (or 47.6%) from the second quarter of last year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter, RadNet reported
Net Loss Attributable to RadNet, Inc. Common Stockholders (&ldquo;Net Loss&rdquo;) of $10.6 million, a decline of approximately
$15.5 million from the second quarter of 2019. Adjusting for the impact of the non-cash change in the fair value of an interest
rate hedge during the quarter on a tax-effected basis of $2.6 million (&ldquo;Adjusted Net Loss&rdquo;), Adjusted Net Loss was
$8.0 million in the second quarter, a decline of $12.9 million from the second quarter of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Per share diluted <FONT STYLE="color: black">Net
Loss for the second quarter was $(0.21), compared to diluted Net Income of $0.10 in the second quarter of 2019 (based upon a weighted
average number of diluted shares outstanding of 50.7 million in 2020 and 50.1 million in 2019). </FONT> Adjusting for the impact
of the non-cash change in the fair value of the interest rate hedge, per share diluted Adjusted Net Loss was $(0.16) in the second
quarter <FONT STYLE="color: black">compared to diluted Net Income of $0.10 in the second quarter of 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: black">Affecting Net
Loss in the second quarter of 2020 were certain non-cash expenses or gains and non-recurring items including: $3.8 million non-cash
expense from the change in the fair value of an interest rate hedge; $1.5 million of non-cash employee stock compensation expense
resulting from the vesting of certain options and restricted stock; </FONT>$859,000 of severance paid in connection with headcount
reductions related to cost savings initiatives; $569,000 gain on the sale of certain capital equipment; and $<FONT STYLE="color: black">1.1
million of non-cash amortization of deferred financing costs and loan discount on debt issuances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter of 2020, as compared
with the prior year&rsquo;s second quarter, MRI volume decreased 39.7%, CT volume decreased 31.6% and PET/CT volume decreased 17.6%.
Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, decreased
43.7% over the prior year&rsquo;s second quarter. On a same-center basis, including only those centers which were part of RadNet
for both the second quarters of 2020 and 2019, MRI volume decreased 39.4%, CT volume decreased 31.7% and PET/CT volume decreased
16.9%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other
exams, decreased 43.4% over the prior year&rsquo;s same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Six Month Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the six months ended June 30, 2020,
RadNet reported Revenue of $472.1 million and Adjusted EBITDA<SUP>(1)</SUP> of $43.0 million. Revenue decreased $88.5 million (or
15.8%) and Adjusted EBITDA<SUP>(1)</SUP> decreased $33.4 million (or 43.7%) from the same six month period last year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the six month period in 2020, RadNet
reported Net Loss of $27.0 million, a decline of approximately $28.1 million over the first six months of 2019. Adjusting for the
impact of the non-cash change in the fair value of an interest rate hedge during the six month period on a tax-effected basis of
$2.8 million, Adjusted Net Loss was $24.2 million in the first six months of 2020, a decline of $25.3 million over the same period
of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Per share diluted <FONT STYLE="color: black">Net
Loss for the first six months of 2020 was $(0.53), compared to a diluted Net Income of $0.02 in the same six month period of 2019
(based upon a weighted average number of diluted shares outstanding of 50.5 million in 2020 and 50.0 million in 2019). </FONT>
Adjusting for the impact of the non-cash change in the fair value of the interest rate hedge, per share diluted Adjusted Net Loss
was $(0.48) in the first half of 2020 <FONT STYLE="color: black">compared to a diluted Net Income of $0.02 in the same period of
2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: black">Affecting Net
Loss for the six month period of 2020 were certain non-cash expenses and non-recurring items including: $3.8 million non-cash expense
from the change in the fair value of an interest rate hedge; $8.1 million of non-cash employee stock compensation expense resulting
from the vesting of certain options and restricted stock; </FONT>$1.1 million of severance paid in connection with headcount reductions
related to cost savings initiatives; and <FONT STYLE="color: black">$2.2 million of combined non-cash amortization of deferred
financing costs and loan discounts related to financing fees paid as part of our existing credit facilities. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Conference Call for Today</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief
Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss
its second quarter 2020 results on Monday, August 10th, 2020 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conference Call Details:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: Monday, August 10, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time: 10:30 a.m. Eastern Time</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dial In-Number: 800-437-2398</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">International Dial-In Number: 786-204-3966</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">It is recommended that participants dial in approximately 5
to 10 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and archived webcasts available at <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>http://public.viavid.com/index.php?id=141056</B></FONT>
or http://www.radnet.com under the &ldquo;Investors&rdquo; menu section and &ldquo;News Releases&rdquo; sub-menu of the website.
An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671
for international callers, and using the passcode 7462345.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulation G: GAAP and Non-GAAP Financial
Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">This press release contains &ldquo;forward-looking
statements&rdquo; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.
Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business,
future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can
generally be identified by words such as: &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;goal,&rdquo;
&ldquo;seek,&rdquo; &ldquo;believe,&rdquo; &ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;strategy,&rdquo;
&ldquo;future,&rdquo; &ldquo;likely,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will&rdquo; and similar references
to future periods. Forward-looking statements in this press release include, among others, statements we make regarding response
to and the expected future impacts of COVID-19, including statements about our anticipated business results, balance sheet and
liquidity and our future liquidity, burn rate and our continuing ability to service or refinance our current indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">Forward-looking statements are neither
historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently
subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our
control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements.
Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could cause our
actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among
others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the ongoing impact of the COVID-19 pandemic
on our business, suppliers, payors, customers, referral sources, partners, patients and employees, including (i) government&rsquo;s
unprecedented action regarding existing and potential restrictions and/or obligations related to citizen and business activity
to contain the virus; (ii) the consequences of an economic downturn resulting from the impacts of COVID-19 and the possibility
of a global economic recession; (iii) the impact of the volume of canceled or rescheduled procedures, whether as a result of government
action or patient choice; (iv) measures we are taking to respond to the COVID-19 pandemic, including changes to business practices;
(v) the impact of government and administrative regulation, guidance and appropriations; (vi) changes in our revenues due to declining
patient procedure volumes, changes in payor mix; (vii) potential increased expenses or workforce disruptions related to our employees
that could lead to unavailability of key personnel; (viii) workforce disruptions related to our key partners, suppliers, vendors
and others we do business with; (ix) the impact of return to work orders in certain states in which we operate; and (x) increased
credit and collectability risks;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital
to fund our business;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to service our indebtedness,
make principal and interest payments as those payments become due and remain in compliance with applicable debt covenants, in addition
to our ability to refinance such indebtedness on acceptable terms;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in general economic conditions
nationally and regionally in the markets in which we operate;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital
to fund the expansion of our business and improvements to our existing facilities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to maintain our current credit
rating and the impact on our funding costs and competitive position if we do not do so;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">volatility in interest and exchange rates,
or credit markets;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the adequacy of our cash flow and earnings
to fund our current and future operations;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in service mix, revenue mix and
procedure volumes; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">delays in receiving payments for services
provided;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">increased bankruptcies among our partner
physicians or joint venture partners;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the impact of the political environment
and related developments on the current healthcare marketplace and on our business, including with respect to the future of the
Affordable Care Act; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the extent to which the ongoing implementation
of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof by federal and state regulators
or related litigation result in a reduction in coverage or reimbursement rates for our services, or other material impacts to our
business;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">closures or slowdowns and changes in labor
costs and labor difficulties, including stoppages affecting either our operations or our suppliers' abilities to deliver supplies
needed in our facilities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the occurrence of hostilities, political
instability or catastrophic events; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the emergence or reemergence of and effects
related to future pandemics, epidemics and infectious diseases; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">noncompliance by us with any privacy or
security laws or any cybersecurity incident or other security breach by us or a third party involving the misappropriation, loss
or other unauthorized use or disclosure of confidential information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement contained
in this current report is based on information currently available to us and speaks only as of the date on which it is made. We
undertake no obligation to publicly update any forward-looking statement, whether written or oral, that we may make from time to
time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>About RadNet, Inc.</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet, Inc. is the leading national provider
of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging
revenue. RadNet has a network of 332 owned and/or operated outpatient imaging centers. RadNet's core markets include California,
Maryland, Delaware, New Jersey and New York. In addition, RadNet provides radiology information technology solutions, teleradiology
professional services and other related products and services to customers in the diagnostic imaging industry. Together with affiliated
radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 8,600 employees.
For more information, visit http://www.radnet.com.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Forward Looking Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release contains forward-looking
statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning
successfully integrating acquired operations, successfully achieving financial guidance, successfully developing and integrating
new lines of business, continuing to grow its business by generating patient referrals and contracts with radiology practices,
and receiving third-party reimbursement for diagnostic imaging services, are forward-looking statements within the meaning of the
Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and
uncertainties, which may cause the Company's actual results to differ materially from the statements contained herein. Further
information on potential risk factors that could affect RadNet's business and its financial results are detailed in its most recent
Annual Report on Form 10-K, as filed with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking
statements, especially guidance on future financial performance, which speaks only as of the date they are made. RadNet undertakes
no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date
they were made, or to reflect the occurrence of unanticipated events. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CONTACTS: </I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>RadNet, Inc.</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mark Stolper, 310-445-2800</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Executive Vice President and Chief
Financial Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 406.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, 2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left; text-indent: -10pt; padding-left: 20pt">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">84,583</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">40,165</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,745</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">154,763</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Due from affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,472</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,242</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">35,720</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">45,004</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">247,520</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">241,174</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">370,188</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367,795</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Operating lease right-of-use assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">448,855</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">445,477</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Total property, equipment and right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">819,043</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">813,272</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OTHER ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">467,803</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">441973</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Other intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,601</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,994</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,336</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,559</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Investment in joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,370</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,470</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Deferred tax assets, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,226</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,548</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Deposits and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">40,104</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,996</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,717,003</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,646,986</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts payable, accrued expenses and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">206,272</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">207,585</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Due to affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,042</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,347</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,700</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,316</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Current finance lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,264</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,283</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Current operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,400</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,206</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Current portion of notes payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">41,715</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">39,691</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">382,393</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">327,428</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">LONG-TERM LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Long-term finance lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,682</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,264</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Long-term operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">424,018</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">420,922</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Notes payable, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">634,840</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">652,704</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other non-current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">40,814</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,529</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,483,747</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,413,847</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">RadNet, Inc. stockholders' equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Common stock - $.0001 par value, 200,000,000 shares authorized; 51,554,760 and 50,314,328 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Additional paid-in-capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">304,012</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">262,865</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accumulated other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(26,098</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,026</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(130,111</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(103,159</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Total RadNet, Inc.'s stockholders' equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">147,808</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">151,685</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">85,448</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">81,454</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">233,256</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">233,139</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total liabilities and equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,717,003</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,646,986</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended June 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six Months Ended June 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">REVENUE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Provision for bad debts</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 40%; font-weight: 400; font-style: normal; text-align: left; text-indent: -10pt; padding-left: 20pt">Service fee revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">155,698</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">258,171</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">404,031</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">500,844</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Revenue under capitation arrangements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">34,868</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">30,926</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">68,099</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">59,803</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left">Total revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">190,566</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">289,097</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">472,130</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">560,647</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Provider relief funding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,475</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,475</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Cost of operations, excluding depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">194,217</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">246,558</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">461,635</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">489,615</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,355</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,083</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,289</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,703</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">(Gain) loss on sale and disposal of equipment and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(569</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">101</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">202</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,073</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Severance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">859</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">371</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,076</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,002</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">215,862</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">267,113</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">506,202</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">531,393</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCOME (LOSS) FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">179</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,984</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,597</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,254</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,831</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,399</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,382</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,694</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(945</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,244</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,900</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,117</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,843</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,843</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other (income) expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(115</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,269</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(108</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,269</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left; padding-bottom: 1pt">Total other expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">13,614</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,424</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">23,217</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">21,846</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">(LOSS) INCOME BEFORE INCOME TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,435</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,560</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(31,814</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,408</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Benefit from (provision for) income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,475</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,969</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,856</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,740</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">NET (LOSS) INCOME</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,960</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,591</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(22,958</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,668</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Net income attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,634</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,692</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,994</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,503</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(10,594</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,899</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(26,952</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,165</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.21</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.10</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.53</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.21</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.10</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.53</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,672,219</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">49,702,869</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,483,274</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">49,490,234</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,672,219</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,144,540</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,483,274</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">49,988,036</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENTS OF CASHFLOWS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six Months Ended June 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left; text-indent: -10pt; padding-left: 20pt">Net loss</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(22,958</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">5,668</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Adjustments to reconcile net loss to net cash provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,289</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,703</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization of operating lease assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,094</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,937</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,900</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,117</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Distributions from joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,438</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization deferred financing costs and loan discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,163</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,021</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Loss on sale and disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">202</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,073</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization of cash flow hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">892</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,843</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,078</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,582</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Other noncash item included in cost of operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(559</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Change in fair value of contingent consideration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(97</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,953</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,018</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,042</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,884</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,331</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,257</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,069</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Deferred taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,678</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,542</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(30,182</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32,268</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,384</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(666</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Accounts payable, accrued expenses and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">27,690</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,860</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 40pt">Net cash provided by operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">131,465</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">44,535</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Purchase of imaging facilities and other acquisitions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,188</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(27,149</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Equity investments at fair value</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(143</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Purchase of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(64,193</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(50,342</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">779</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">760</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of equity interests in a joint venture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">132</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Equity contributions in existing joint ventures</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(103</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(67,602</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(76,845</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Principal payments on notes and leases payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,814</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,320</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Payments on Term Loan Debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,648</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(19,469</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from issuance of new debt, net of issuing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">97,144</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from Payment Protection Program</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of noncontrolling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,275</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Contribution from a noncontrolling partners</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">250,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">236,200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Payments on revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(250,900</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(264,200</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Proceeds from issuance of common stock upon exercise of options</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">50</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Net cash (used in) provided by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(19,439</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">52,430</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">EFFECT OF EXCHANGE RATE CHANGES ON CASH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET INCREASE IN CASH AND CASH EQUIVALENTS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,418</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,115</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">40,165</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,389</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">84,583</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">30,504</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Cash paid during the period for interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">22,826</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23,292</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"><B>RADNET,
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"><B>RECONCILIATION
OF GAAP NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS TO ADJUSTED EBITDA<SUP>(1)</SUP></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>(IN THOUSANDS)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">Three Months Ended</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left">Net Income (Loss) Attributable to RadNet, Inc. Common Shareholders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(10,594</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">4,899</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,831</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,399</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Provision (Benefit) for Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,475</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,969</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Depreciation and Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,355</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,083</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Other Expenses (Income)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(115</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,269</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Severance Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">859</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">371</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Loss (Gain) on Sale of Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(569</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">101</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Non-cash Change in Fair Value of Interest Rate Hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,843</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Plus Non Cash Employee Stock Compensation</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,456</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,044</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt"><B>Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><SUP>(1)</SUP></FONT></B></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">22,591</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">43,135</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">Six Months Ended</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left">Net Income (Loss) Attributable to RadNet, Inc. Common Shareholders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(26,952</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,165</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,382</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,694</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Provision (Benefit) for Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,856</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,740</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Depreciation and Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,289</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,703</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Other Expenses (Income)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(108</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,269</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Severance Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,076</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,002</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Loss on Sale of Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">202</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,072</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Non-cash Change in Fair Value of Interest Rate Hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,843</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Plus Non Cash Employee Stock Compensation</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,078</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,583</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-weight: bold; font-style: normal; padding-bottom: 2.5pt"><B>Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><SUP>(1)</SUP></FONT></B></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">42,954</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">76,228</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">PAYOR CLASS BREAKDOWN</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp;
&nbsp; &nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Second Quarter</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 85%; text-align: left">Commercial Insurance/Other Patient Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">52.4</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicare</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18.4</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Capitation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18.3</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Workers Compensation/Personal Injury</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.9</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Medicaid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.3</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other/Non Patient</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.8</TD><TD STYLE="padding-bottom: 1pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET PAYMENTS BY MODALITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
&nbsp; &nbsp; &nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Second Quarter</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%">MRI</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">36.1</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.8</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.2</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">34.9</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.9</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.2</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>PET/CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.2</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>X-ray</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.3</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.9</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Ultrasound</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.1</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Mammography</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.3</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Nuclear Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.1</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.2</TD><TD STYLE="padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.9</TD><TD STYLE="padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5.1</TD><TD STYLE="padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5.2</TD><TD STYLE="padding-bottom: 1pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U><BR STYLE="clear: both">
</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Footnotes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>&nbsp;</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: windowtext"><SUP>(1)</SUP>
The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations
and adjusted for losses or gains on the sale of equipment, other income or loss, debt extinguishments and non-cash equity compensation.
Adjusted EBITDA</FONT> includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling
interests in subsidiaries<FONT STYLE="color: windowtext">, and is adjusted for non-cash or extraordinary and one-time events taken
place during the period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA is reconciled to its nearest
comparable GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management
and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt.
Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA
should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing
activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance
or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying
methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: windowtext"><SUP>(2)</SUP>
As noted above, the Company defines Free Cash Flow as </FONT>Adjusted EBITDA less total Capital Expenditures (whether completed
with cash or financed) and Cash Interest paid. <FONT STYLE="color: windowtext">Free Cash Flow is a non-GAAP financial measure.
</FONT>The Company uses Free Cash Flow because the Company believes it provides useful information for investors and management
because it measures our capacity to generate cash from our operating activities. Free Cash Flow does not represent total cash flow
since it does not include the cash flows generated by or used in financing activities. In addition, our definition of Free Cash
Flow may differ from definitions used by other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Free Cash Flow should not be considered
a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement
data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA
is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric,
as presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>radnet_ex9902.htm
<DESCRIPTION>TRANSCRIPT OF CONFERENCE CALL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.2</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RadNet, Inc. &ndash; Second Quarter
2020 Financial Results Conference Call, August 10, 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>C O R P O R A T E P
A R T I C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper, </B><I>Executive Vice
President and Chief Financial Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, </B><I>Chairman,
President and Chief Executive Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>C O N F E R E N C E
C A L L P A R T I C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut, </B><I>Jefferies</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal, </B><I>Sidoti &amp;
Co. LLC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>P R E S E N T A T I
O N</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good day, and welcome to the RadNet Inc.
Second Quarter 2020 Financial Results Call. Today&rsquo;s conference is being recorded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I would like to turn the
conference over to Mr. Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, Inc. Please go ahead, sir.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Good morning, ladies and gentlemen,
and thank you for joining Dr. Howard Berger and me today to discuss RadNet&rsquo;s Second Quarter 2020 Financial Results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we begin today, we&rsquo;d like
to remind everyone of the Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. This presentation contains
forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, specifically, statements
concerning anticipated future financial and operating performance and liquidity; our response to, and the expected future impact
of COVID-19; our ability to stabilize and continue to grow the business by generating patient referrals and contracts with radiology
practices; recruiting and retaining technologists; consummating acquisitions and joint ventures; receiving third party reimbursement
for diagnostic imaging services; successfully integrating acquired operations; generating revenue and Adjusted EBITDA for the acquired
operations as estimated, among others, are forward-looking statements within the meaning of the Safe Harbor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are based on
Management&rsquo;s current preliminary expectations and are subject to risks and uncertainties which may cause RadNet&rsquo;s actual
results to differ materially from the statements contained herein. These risks and uncertainties, including those risks set forth
in RadNet&rsquo;s reports filed with the SEC from time to time, including RadNet&rsquo;s Annual Report on Form 10-K for the year
ended December 31, 2019 and our quarterly report on Form 10-Q for the quarter ended June 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Undue reliance should not be placed on
forward-looking statements, especially guidance on future financial performance, which speaks only as of the date it is made. RadNet
undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances
after the date they were made, or to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that, I&rsquo;d like to turn the call
over to Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark. Good morning, everyone,
and thank you for joining us today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On today&rsquo;s call, Mark and I plan
to provide you with highlights from our second quarter 2020 results, give you more insight into factors which affected this performance,
and discuss our future strategy. After our prepared remarks, we will open the call to your questions. I&rsquo;d like to thank all
of you for your interest in our Company and for dedicating a portion of your day to participate in our conference call this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we start, I would like to say, on
behalf of myself and the entire RadNet team, we hope all of you and your loved ones are healthy and staying safe. We are extremely
grateful for all of our stakeholders, including our employees, business partners, lenders, and shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This morning, Mark and I will pick up where
we left off last quarter&rsquo;s financial results call, by giving you a further understanding of what we have been facing under
COVID-19, the actions we have taken to reduce costs and conserve cash, our current and projected liquidity position, our business&rsquo;
recovery progress, and some discussion around the post-COVID operating opportunity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d like to start off by giving you
a status update on where our business stands and how it has been impacted by COVID-19. As a reminder, after having strong operating
results in January and February months of this year, that performed ahead of our original internal operating plan, we began to
see our volumes drop dramatically, beginning the third week of March. This is when we began to take swift and decisive actions
to secure our business from the material drop in the anticipated procedural volumes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We analyzed all aspects of our business
and focused on ways to most effectively reduce our cash spend. We created a multiform plan to impact major expenses and cash flow
categories. Specifically, we focused on reducing salaries and professional fees, and lowering our facilities&rsquo; rental payments.
We investigated every local market in which we operate to identify centers we could temporarily close, and where we felt, with
a high degree of confidence, we could direct patient volume into facilities that would remain open.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also evaluated our large categories
of cash spend and identified vendors that would work with us to lower our costs or defer payments. Our objective is to act quickly
and to institute these programs beginning April 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First, we analyzed all of our 332 locations
and identified sites in our clustered approach that could be temporarily closed, and whose business could be consolidated to nearby
facilities. During the stay-at-home orders, we closed 102 of our locations. By temporarily closing facilities and redirecting their
patient flow to other RadNet sites, we were able to substantially reduce employee cost, utilities, repairs and maintenance, and
other center-level operating costs, all while preserving the revenue we would have otherwise recognized at the closed sites. Our
geographically-concentrated approach and central scheduling departments were instrumental in making this happen. Temporarily closing
these facilities enabled us to furlough about 3,600 employees of our roughly 8,600 total team members. While furloughed, we continue
to fund the benefit plans of these employees, but are able to suspend payment of salaries and corresponding employee taxes. We
assisted these employees with seeking unemployment benefits, including the unemployment subsidies from Federal and state-funded
programs. In addition to the furloughs, we cut the salaries of the vast majority of non-center level employees who remain working.
These cuts were led by our Executive Management team, who remain at 50% of their normal salaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our landlords also greatly contributed
to our cash conservation measures. Most of our landlords agreed to three to six-month full or partial deferrals of rent payments,
and most are providing us 6 to 12 months to repay these deferrals. In certain cases, we are looking to extend the terms of leases
in exchange for deferrals and other rent concessions. As a result, cash expenditures from rent payments in (phon) the second quarter
were reduced by almost 70%, though through GAAP accounting, required us to expense all rents, whether or not they were paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, all of our lessors with whom
we have operating leases on equipment, including the OEMs and third party finance companies, agreed to structure rental agreements
and allow us, starting with the payment we would have made in April, to defer up to six months and add these amounts to the back-end
buyout of the leased equipment. We also suspended new capital projects. The vast majority of capital expenditures we made during
the first half of the year were for projects and commitments that were put in place prior to the onset of the COVID pandemic.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, our variable expensing substantially
decreased during the second quarter with the low of procedural volume. Most significant of these variable outflows are payments
that were made to third party contracted radiology groups, which generally are a function of revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other variable expenses that adjusted with
revenue and procedural volumes include medical and pharma supplies, utilities, equipment repair and maintenance, and certain employee-related
expenses such as travel, meals, and other employee expense reimbursement items. All these expenses and cash outflows adjusted more
than proportionately to our lower procedural volume levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;m extremely proud to say that these
costs and liquidity shaving (phon) measures resulted in an $84.6 million cash balance at quarter-end and are being undrawn on our
$137.5 million revolving credit facility. Despite our revenue declining approximately $125 million since the beginning of the COVID-19
pandemic, our aggressive actions allowed us to achieve positive EBITDA and no cash burn. This is pretty remarkable in a business
that has a higher component of fixed cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our cash balance was enhanced by payments
we received in April and June, from two separate appropriations under the CARES Act, and advantage we received from Medicare and
non-private payor. Specifically, we received $25.5 million under the $50 billion appropriation of the Coronavirus Aid and Relief
and Economic Security Act, or CARES Act. This allocation to RadNet was calculated based on our share of overall Medicare billings,
relative to all Medicare providers during 2019. We do not anticipate being required to repay this money.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to this grant money, we received
$39.4 million in accelerated Medicare advanced payments. This money was to be repaid to CMS over a 90-day period, beginning later
this month, and should be repaid through the adjudication of future Medicare services we provide. Furthermore, one California insurance
company provided us a $5 million advance to be repaid against future collections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As I mentioned, in last quarter&rsquo;s
financial results call, our procedural volumes hit a trough during mid-April, whereby our procedural volume declined to about 28%
on a blended basis nationwide, of the pre-COVID per-day volumes. We began to see a steady recovery in early May, which has continued
to the present day. The week before last, our procedural volumes returned to about 90% of the pre-COVID per-day procedures. While
we were impacted by the tropical storm that hit the Mid-Atlantic and Northeast last week, we expect to recover quickly from this.
I am also very happy to report that we have brought back approximately 2,500 of the 3,600 employees who were furloughed, and we&rsquo;ve
been able to return a portion of our corporate staff, which have salary cuts, to their normal base pay.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Throughout the COVID period, our capitation
business has remained strong. While our aggregate fee-for-service revenue, excluding capitation, decreased 39.7% from last year&rsquo;s
second quarter, our capitation revenue actually increased 12.7% from the second quarter of 2019. Because we had paid a fixed capitation
amount for enroll rate, managed by the medical groups with whom we contract, our capitation revenue and the associated cash flow
have remained strong throughout the COVID period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Enrollment for these HMO patients and our
contracted medical groups has remained intact as patients and their employers, even for those who have been furloughed, have continued
to pay healthcare premiums.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before I turn the call over to Mark to
discuss financials, I&rsquo;d again like to take this moment to recognize our workforce. Our center-level employees and their managers
continue to come to work each day to service our medical communities with the essential services provided by the RadNet centers,
and patients in need, despite the associated risk which we have done everything in our power to mitigate. I am certainly grateful
for these employees, as RadNet as a Company can play an important role in an unprecedented time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I&rsquo;d like to turn the
call back over to Mark to discuss some of the highlights of our second quarter 2020 performance. When he is finished, I will make
some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Howard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;m now going to briefly review our
second quarter 2020 performance, and intend to highlight what I believe to be some material items. I will also give some further
explanation of certain items in our financial statements, as well as provide some insights into some of the metrics that drove
our second quarter 2020 performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In my discussion, I will use the term Adjusted
EBITDA, which is a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation,
and amortization, and excludes losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishments,
and non-cash equity compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA includes equity earnings
in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted
for non-cash or extraordinary and one-time events taking place during the period. A full quantitative reconciliation of Adjusted
EBITDA to net income or loss attributable to RadNet, Inc. common shareholders is included in our Earnings release and our current
report on Form 8-K, filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that said, I&rsquo;d now like to review
our second quarter results. For the second quarter of 2020, RadNet reported revenue of $190.6 million and Adjusted EBITDA of $22.6
million. Revenue decreased to $98.5 million or 34.1% as a result of the impact of COVID-19. Adjusted EBITDA decreased $20.5 million
or 47.6%. We were extremely pleased at our ability to reduce expenses, particularly salaries and professional fees, by approximately
$45 million relative to last year&rsquo;s same quarter. We achieved this through temporarily closing facilities, furloughing workforce
and instituting salary cuts for general and administrative staff.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter of 2020 as compared
to the prior-year second quarter, MRI volume decreased 39.7%; CT volume decreased 13.6%; and PET CT volume decrease 17.6%. Overall
volume, taking into account routine imaging exams inclusive of X-ray, ultrasound, mammography, and all other exams decreased 43.7%
over the prior-year second quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the second quarter of 2020, we performed
1,137,287 total procedures. The procedures were consistent with our multimodality approach, whereby 73.8% of all the work we did
by volume was from routine imaging. Our procedures in the second quarter of 2020 were as follows. Note that the CT volumes for
last year have been restated to account for a change we made as of January 1 of this year in how we account for one of our CT CPT
codes. The comparative numbers that follow are on an apples-to-apples basis: 171,047 MRIs, as compared with 283,717 MRIs in the
second quarter of 2019; 117,732 CTs, as compared with 172,076 CTs in the second quarter of 2019; 8,935 PET CTs, as compared with
10,840 PET CTs in the second quarter of 2019; and 839,567 routine imaging exams, compared with 1,554,869 of these exams in the
second quarter of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter, RadNet reported
net loss attributed wealth to RadNet, Inc. common shareholders of $10.6 million, a decline of approximately $15.5 million from
the second quarter of 2019. Adjusting for the impact of non-cash change in the fair value of an interest rate hedge during the
quarter, on a tax-effective basis of $2.6 million, adjusted net loss was $8 million in the second quarter, a decline of $12.9 million
from the second quarter of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Per-share diluted net loss for the second
quarter was -$0.21 per share, compared to diluted net income per share of $0.10 in the second quarter of 2019, based upon weighted
average number of diluted shares outstanding of 50.7 million shares in 2020, and 50.1 million shares in 2019. Adjusting for the
impact of the non-cash change in the fair value of the interest rate hedge, per-share diluted adjusted net loss was -$0.16 in the
second quarter, compared to per-share diluted net income of $0.10 in the second quarter of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Affecting net loss in the second quarter
of 2020 were certain non-cash expenses or gains, and non-recurring items including the following: $3.8 million of non-cash expense
from the change in the fair value of an interest rate hedge; $1.5 million of non-cash employee stock compensation expense, resulting
from divesting of certain options and restricted stock; $859,000 of severance paid in connection with headcount reductions related
to cost savings initiatives; $569,000 gain on the sale of certain capital equipment; and $1.1 million of non-cash amortization
of deferred financing costs and loan discounts on debt issuances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overall, GAAP interest expense for the
second quarter of 2020 was $10.8 million. This compares with GAAP interest expense in the second quarter of 2019 of $12.4 million.
Cash paid for interest during the period, which excludes non-cash deferred financing expenses and accrued interest, was $12.9 million,
as compared with $13 million in the second quarter of last year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to our balance sheet, as of
June 30, 2020, unadjusted for bond and term loan discounts, we had $604.5 million of net debt, which is our total debt at par value
less our cash balance. This compares with $706.1 million of net debt at June 30, 2019. Note that this debt balance includes New
Jersey Imaging Network debt of approximately $56.1 million, for which RadNet is neither a borrower nor a guarantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2020, we were undrawn on
our $137.5 million revolving line of credit, and had a cash balance of $84.6 million. We expect that this cash balance could grow
by year-end, absent any acquisitions or a major setback from a second wave of COVID-19.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At June 30, 2020, our accounts receivable
balance was $125.7 million, a decrease of $29 million from year-end 2019. The decrease in accounts receivable is mainly the result
of the dramatic decline in our procedural volumes and revenue since March, and our cash collections on previously existing accounts
receivable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our day sales outstanding, or DSO, was
49 days at June 30, 2020, higher by approximately 4.3 days as of the year-end of 2019. The higher DSO was primarily a function
of the lower revenue in the second quarter. As revenue normalizes, we expect DSOs to return to the low to mid 40 level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through June 30, 2020, we had total capital
expenditures, net of asset dispositions, of $64.2 million. This includes $5 million of capital expenditures of the New Jersey Imaging
Network, our joint venture with RWJ Barnabas. Note that, each year, we frontload the majority of our capital decisions into the
first half of the year. Most of what we paid for during the first half of this year was for equipment delivered to the Company
or construction projects that were in-process before the start of COVID-19. As Dr. Berger mentioned in his remarks, we have suspended
all new capital projects for the remainder of the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;ll now take a few minutes to give
you an update on 2021 reimbursement, and discuss what we know with regards to 2021 anticipated Medicare rates. With respect to
Medicare reimbursement, last week, we received a matrix for proposed rates by CPT codes, which is typically part of the physician
fee schedule proposal that is released about this time every year. We have completed an initial analysis and compared those rates
to 2020 rates. We volume-weighted our analysis using expected 2021 procedural volumes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the proposal, CMS has moved forward
with an increased reimbursement for valuation and management CPT codes which favor certain physician specialties that regularly
bill for these types of services, particularly primary care doctors. CMS has proposed doing so with budget neutrality, meaning
that it is proposing to reallocate reimbursement from physicians who rarely bill for these E&amp;M codes, to physicians who regularly
bill for these codes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the proposed rule, CMS has initiated
a 10.6 decrease in the conversion factor used to calculate Medicare reimbursement for all specialties in 2021. For radiology, CMS
has made a material upward adjustment to the technical RVUs in the reimbursement formula. These RVUs are multiplied by this now-lower
conversion factor to determine our reimbursement. Our initial analysis of these opposing forces show that RadNet will suffer an
approximately $11 million revenue hit in 2021 from Medicare. While we are not pleased with this outcome, we have plans in place
to more than fully mitigate this potential cut.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to affect the cost and cash savings
measures we instituted during this COVID-19 period, which Dr. Berger discussed in his prepared remarks, we had to re-evaluate every
aspect of our business. The mitigants for this Medicare cut next year come from this exercise directly, and come predominantly
from four areas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><BR>
First, there will be permanent staffing reductions, both from regional operations as well as corporate support functions. Second,
we have identified significant reductions in future employee travel and reimbursement expenses. Third, we will be consolidating
certain sites and modalities in order to lower regional operating costs. Finally, we have rate increases that will go into effect
in 2021, from private payers and capitated medical groups.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are confident that the aggregate of
these cost savings will exceed the proposed CMS rate cut. Of course, the proposed rates for the physician fee schedule are subject
to comment, from lobbying and industry groups, and there is no assurance that the final rule to be released in the November 2020
timeframe will reflect these same proposed rates. There are many lobbying groups from the various medical specialties aggressively
opposing the budget neutrality aspect of the E&amp;M code reimbursement changes, including radiology&rsquo;s two main lobbying
forces, the Association for Quality Imaging, the AQI, and the American College of Radiology, the ACR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In light of the impact of COVID-19 on all
physicians, radiologists included, we remain hopeful that CMS may decide not to move forward with the budget neutrality requirements.
In November, during our third quarter financial results call, we hope to have more to update you on this matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d now like to turn the call back
to Dr. Berger who will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the first part of my prepared remarks,
I discussed our performance, the actions we have taken during the COVID period and current status of the business. I&rsquo;d now
like to take a few moments to discuss the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I strongly believe that the COVID pandemic
will be a catalyst for opportunity. As I mentioned during our first quarter financial results call, COVID has caused us to analyze
everything we do as a Company, and evaluate how we deliver our services. It has necessitated that we closely evaluate how we are
spending our money, and ways that we can become more efficient. We have learned a lot during this exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As Mark mentioned in his discussion of
reimbursement and the mitigation of the proposed Medicare cuts for next year, in a post-COVID environment, we will reduce what
we had historically been spending on employee travel and other reimbursed expenses. We will be able to staff our centers and supporting
general and administrative functions more efficiently. We will be able to procure medical supplies, equipment services, and perform
general and administrative functions at a lower cost. There are markets where we will consolidate centers, thereby eliminating
costs permanently.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I also believe that the post-COVID environment
will provide us with opportunities to accelerate our growth. As difficult as this period has been for RadNet, smaller operators
have had even more challenging time. Most of our competitors lack the scale, capital, and human resources to emerge from the COVID
with financial and operating strength. As a result, we expect more M&amp;A activity for us in the post-COVID period, at multiples
that are consistent with that we have paid in the past. This issue is going to be more important with the Medicare reimbursement
reductions proposed for 2021, (inaudible) implemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Furthermore, during the COVID period, much
of the outpatient business that has historically been performed within hospitals has shifted to ambulatory providers such as RadNet.
This means that patients and referring physicians will have become accustomed to using outpatient providers as opposed to the hospital
systems, and we don&rsquo;t believe this business will be captured by hospitals once the COVID period ends. This could have a material
impact on our volumes in the future and could accelerate the existing trend, mostly because of the differential in cost of hospitals
using outpatient business to ambulatory free-standing providers. The acceleration of this trend could also drive more hospitals
towards joint ventures and partnerships, which now represent over 25% of all RadNet facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, during the COVID-19 period,
Telehealth and telemedicine has flourished. I believe this is here to stay. Because telemedicine does not allow for traditional
physical exams, I believe physicians will order more diagnostic tests and rely on their results for diagnosing and treating their
patients at a distance. In particularly, I believe this will drive increased utilization of routine imaging, specifically ultrasound
and X-ray, as tools that will be utilized earlier in the patient diagnosis stages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Furthermore, artificial intelligence will
have an even more important role in healthcare, post-COVID. There will likely be more of an emphasis on streaming tools and elements,
and diagnostic imaging will play an important role in these initiatives. As many of you have seen, last week we announced a multifaceted
collaboration agreement with Hologic, focused on improving women&rsquo;s health. Specifically, Hologic will contribute capabilities
and insights behind its market-leading hardware and software, and RadNet will share data with Hologic produced by RadNet&rsquo;s
fleet of high-resolution mammography systems, the largest in the nation. The data will be used to train and refine current and
future products based on artificial intelligence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet will also provide in-depth knowledge
of patient workflow needs to help make a positive impact across the breast care continuum. Both companies will work together to
enable new joint market opportunities and further efforts to build clinician confidence, and develop and integrate new AI technologies.
The collaboration will also result in the upgrade of RadNet&rsquo;s fleet of Hologic mammography machines, to Hologic&rsquo;s newly
added 3DQuorum and Genius 3D imaging technology. We see this partnership between our two companies as potentially transformative
for both organizations, and for the future of breast health. We look forward to keeping you informed as the collaboration progresses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Even in this challenging time, we continue
to be very optimistic about the future of RadNet, and we expect to emerge from COVID as the best-positioned Company in our industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator, we are now ready for the question-and-answer
portion of the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Ladies and gentlemen, if you
would like to ask a question, please signal by pressing star, one on your telephone keypad. If you&rsquo;re using the speakerphone,
please make sure your mute function is turned off to allow your signal to reach our equipment. Once again, press star, one to ask
a question. We will pause for just a moment to allow everyone an opportunity to signal for questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will now take our first question from
Brian Tanquilut with Jefferies. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hey, good morning, guys, and congrats for
the hard work that you guys did the past quarter, and (inaudible).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I guess, Mark, I&rsquo;ll just jump right
in to the Medicare cuts, the $11 million revenue hit. As I think about it, there is a physician component in there, and then there&rsquo;s
a technical component. Is part of that $11 million passable to the physicians that are in the independent radiology groups that
you reimburse, on a direct pay or pass-through basis?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. The way the cuts are proposed to be
implemented is that the conversion factor in the Medicare fee schedule is set to decline by 10.6%, and I think it&rsquo;s a total
of $3.83. It&rsquo;s moving from $36 and change to $33 and change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That then is applied, that conversion factor
is then multiplied to both the technical and professional RVUs. In the case of radiology, what CMS is proposing is that the technical
RVUs are actually going up, so that the proportion of the technical RVUs to the total RVUs, which then incorporate the professional
RVUs, get higher. That ratio is used in the formulas that we have with our third party affiliated medical groups to determine what
portion of the revenue and our cash collections that our professional fees get. Our professional groups are going to be absorbing
a significant amount of this cut with us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The $11 million that I mentioned is net
of the portion of our physician groups that are going to be absorbing a portion of this cut.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got you, okay.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The technical RVUs going up was a function
of Medicare reevaluating the cost of equipment, which is does from time to time. They have talked about this, along with this E&amp;M
code cut, really, for the last several years. I think as they introduce the conversion factor decrease, they then readjusted the
technical component of the RVUs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got you. Then Mark, as I think about&mdash;just
on an EBITDA growth perspective without going through guidance, obviously, so you laid out your mitigation efforts. Do you think,
apples-to-apples, if COVID did not happen and this cut wouldn&rsquo;t have happened, you may have had seen a certain level of growth
in EBITDA or thinking of an EBITDA level for next year&mdash;but all the cost cuts that you&rsquo;re putting through, do you think
that 2021 EBITDA that you would have contemplated in January of 2020 would still be within the same ballpark, as we&rsquo;re accounting
for both the Medicare cuts and the cost cuts that you put through?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think I understand what you&rsquo;re
asking. I mean, some of these cuts or mitigants that are going into place in 2021 would have been executed anyway, just because
we constantly are looking for areas of our business that we can improve on. But I would tell you that the exercise that we&rsquo;ve
gone through during the pandemic, which was necessitated by the fact that our revenue was so pressured, and our patient volume
was so pressured, also uncovered other areas of the business where we feel we can save money.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;ll give you one example of that,
which is employee travel and reimbursement expenses. We have historically had a fair bit of travel as our facilities are across
six states, some on the East Coast, some on the West Coast. Along with that travel is the cost of airlines and hotels, and Ubers,
and all related expenses. Well, we&rsquo;ve been operating just fine over the last few months with almost no travel and very little
employee reimbursement expenses. That&rsquo;s showed us that some of the travel that we&rsquo;ve enjoyed over the past several
years is&mdash;we&rsquo;re able to reduce that significantly. That&rsquo;s one of the things that has come directly out of COVID
that perhaps we wouldn&rsquo;t have fully appreciated if we hadn&rsquo;t had the necessity to look at every aspect of our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brian, it&rsquo;s Howard. Maybe to perhaps
amplify the question that you&rsquo;re answering, there are certain aspects of our business that we look at all the time to try
to become more efficient in the delivery of our services. That would have happened regardless of COVID. I think what the COVID
experience has allowed us to do is reduce the Company down to its foundation and reevaluate it. As you are well aware, the Company
has grown significantly over the past six, seven years, primarily through acquisitions. Given our particular strategy of being
clustered in specific regional areas, we appeared to have had facilities, or legacy facilities, that we continued to operate and
were reluctant to make any significant changes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This COVID period has allowed us to look
at the greater flexibility that patients and referring physicians are willing to undergo, as to where they can send their patients.
In fact, we&rsquo;ve identified a number of our centers where we believe we can eliminate those centers and consolidate into our
more centers of excellence, to both handle that volume and probably do it on a more efficient basis. In a way, we&rsquo;re trying
to take this opportunity to really look at the business, and in our unique strategy that I think is unlike any other in the medical
industry&mdash;or healthcare industry, I should say, look at what we can do to become more efficient in the way that we deliver
our services&mdash;and also the quality, I might add, for that.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think that that will be a byproduct which
will be a significant mitigant to the Medicare reimbursement cuts that we will experience most likely in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Excellent, that makes sense. Then I guess,
Mark or Howard, so let&rsquo;s think about the re-ramp of your business; now you&rsquo;re running at 90% on an average basis, pre-COVID.
How should we be thinking about the re-ramp of expenses? I&rsquo;m trying to think about testing (phon) levels at the centers,
and then&mdash;I know you cut compensation by up to 50%. What is that re-ramp going to look like over the back half of 2020?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, we actually have two parts, Brian.
First, on the revenue side of getting above the 90% number that we&rsquo;re currently at; there&rsquo;s two factors that are at
play here that will very much depend upon the continued COVID experience. Namely, that some of our MRI volume has been impacted
by the lack of sports that have been curtailed, virtually at every level. I think excluding professional sports, which is a very
limited number of people to begin with relative to the total population, but every other level, whether you&rsquo;re talking about
college, high school, little league, pickup clubs, even just reaching (phon) scrimmages or pickup games that individuals participate
in have been substantially curtailed. Sports medicine is a huge driver of imaging, particularly MRIs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We&rsquo;ve seen that a number of our orthopedic,
surgical referrals and colleagues have been slow to recover to more normal levels, and we think that that&rsquo;s what this is
due to. It&rsquo;s very likely that the impact of sports medicine from COVID is likely to extend well into next year. Our MRI volume,
I believe, will be challenged, at least in that regard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In regard to the other area where we&rsquo;re
seeing a big lag is in routine X-rays, particularly chest X-rays. As the COVID impact very much curtailed the need to run physicals
and routine annual visits by patients to doctors, as well as the substantial decrease in elective surgeries, which almost always
require a chest X-ray to be done, has been a pretty dramatic impact on the business, and which is the biggest lagging valley to
return. I think again, while I&rsquo;m very pleased at the level of 90% we&rsquo;ve achieved, we are still very focused on monitoring
the rest of that growth above 90%. We think we&rsquo;ll get back to that 100%, but probably not until maybe the second quarter
of next year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In regards to the expenses, as Mark mentioned
in his remarks, about two-thirds of the employees that were furloughed have now been brought back. Many that were furloughed have
either chosen not to return, or through some of our consolidation, will probably be permanently terminated. I think that is something
that we are going to continue to benefit from, along with the closing, permanent shuttering and closing of centers that will help
reduce the overall cost of running any center, which include not only the staffing but equipment, rent and utilities, and other
expenses that go along with that.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think our operating results for the third
and fourth quarter of this year, assuming that we don&rsquo;t have any more serious waves or surges, whether you call it a spike
of the first wave or a surge from the second wave, it can get a little bit much with the way they all try to spin this designation.
But as long as we don&rsquo;t suffer any major setbacks in our markets, then I believe we are very comfortable with&mdash;not only
where we&rsquo;re going to be from an operating standpoint, but other important things like our cash liquidity and our covenant
for our leverage ratios.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In short, I think, while I believe the
senior Management will continue through the remainder of this year at the 50% reduction that has been taken, we&rsquo;re anxious
to get the rest of the Company&rsquo;s employees back who aren&rsquo;t already back at their full base pay, back to that, as the
procedural volumes and performance allows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got you. Then as I think about M&amp;A,
I&rsquo;m guessing the drag that you saw this quarter on your earnings&mdash;I know the government obviously provides support,
but net-net, I can imagine that the smaller guys or even the medium-sized regionals are struggling with this. Do you think that&rsquo;s
opened M&amp;A opportunities for you, or are you more focused right now on capital conservation, given the ongoing COVID uncertainty?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, I think right now, we&rsquo;re focused
on capital conservation. While I think the M&amp;A opportunities will present themselves to us and we will look at them very carefully,
I think we&rsquo;ll need to be very targeted, as we have always been, in making certain that those M&amp;A activities primarily
occur inside of the regions in which we currently operate. I think, as we gain more and more presence in those markets, it benefits
us throughout the entire organization and makes us a more profitable Company, more so than going into new regions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That being said, I believe that the entire
healthcare industry is reevaluating the ambulatory strategies, outpatient strategies. It may be a better opportunity for us to
perhaps go into new markets, as long as they fit the criteria of having a path forward for us to become a significant player in
those markets, and partnering with a health system that has only be shown to be a very valuable part of the RadNet strategy. I
don&rsquo;t want to rule anything out. We&rsquo;re comfortable in our current position, both with the highest liquidity that the
Company has ever experienced, and confidence in our future operating results. Perhaps now is the time to look at opportunities
that may not have been as obvious in the pre-COVID period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Howard, last question for me, Hologic;
if you don&rsquo;t mind giving us a little more color. I know you talked about it a little bit in your prepared remarks, but where
do you see that partnership going? How does it blend in with the overall RadNet strategy longer-term with AI in the background?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian. It&rsquo;s a great question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As I&rsquo;ve said in prior earnings calls,
and as hopefully everybody has noticed with the acquisition of an artificial intelligence company called DeepHealth, we have felt
very strongly that artificial intelligence in general for the healthcare industry, but in particular for radiology imaging, will
be transformative. Where I think this intersects with the Hologic collaboration is that breast imaging and mammography is a quintessential
aspect or example, I should say, of potential population health. It is truly a screening exam. We believe that screening exams,
such as for the prostate, the lung, the colon, are opportunities for the future to better manage population health, and for which
we want to be in the forefront.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With the Hologic collaboration, two things
are happening. Number one, approximately 95% of our entire mammography (inaudible) systems are Hologic, and every one of those
systems, within the next 12 months, will be upgraded and/or replaced with the latest Hologic technology, which not only involves
high resolution detectors, but have more artificial intelligence to help read the exams faster and more accurately. It will allow
us at least about 1.2 million or more mammography exams annually, which is approximately 4% of all mammography done in the United
States, all the screening mammography done in the United States, and for which Hologic will be getting that data to allow them
to further evaluate the clinical efficacy and accuracy of its technology, along with our development of artificial intelligence,
to read more accurately and diagnose earlier, breast cancers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That, combined with a robust plan to incorporate
other imaging and screening data for patients, will, I believe, allow us to be more aggressive in going to the payors and patients
and offering our products to advance population health and have different potential reimbursement models, maybe like capitation
or all the risk-sharing models, which I think are very much part of the future. I think for both Hologic and for RadNet, the potential
implications of this as it relates to, certainly, breast health in general, as well as an overall appreciation of the benefits
of artificial intelligence are going to be extraordinarily consequential.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awesome, Howard, thank you so much. Appreciate
(inaudible) this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian. Stay well.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will now take our next question from
Mitra Ramgopal with Sidoti. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, hi, good morning, thanks for taking
the questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First, Howard, I was wondering if you could
give a sense in terms of the geography, with the (inaudible) you&rsquo;re seeing, volumes, how much of that&mdash;I assume most
of that is essentially from New York, but then you&rsquo;re seeing a surge of cases in California in terms of COVID. I was wondering
how the mix has changed from maybe a few months ago.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi, Mitra. Yes, the growth on the East
Coast has been steady growth, with many of our markets outside of metro New York achieving closer to 100% of the pre-COVID levels.
That has been a very pleasant development for us. As you can imagine, with the stringent procedures and oversight in New York,
which I am a firm believer of both the results as well as the appropriateness of, New York has been slow to return but is now gaining
a little bit of additional momentum, which I think will be helped by Governor Cuomo&rsquo;s recent announcement of the reopening
of the schools.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I would expect that the East Coast will
continue, assuming there&rsquo;s no further surges in its growth, in its procedural volume growth. California has been challenging;
it was ahead of the East Coast initially, but as the surge here in California, like many other states, notably Florida, Texas,
and Arizona, has gotten out of control, there&rsquo;s been a bit of a flattening and maybe even a very slight decrease here in
California, which we anticipated. Fortunately, as you&rsquo;re aware, a disproportionate amount of our revenue in California is
from our capitation contracts, which brings revenue to the Company has remained unabated and, in fact, has actually grown slightly,
as more people, I think, are seeking that form of insurance coverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While I believe we&rsquo;re at a bit of
a pause here, I expect this will come under control, probably within the next 30 to 60 days, and our growth will continue here,
but at least we have the benefit of the more stable and reliable capitation contracts to rely on.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I also think this represents an opportunity
for us to actually do more capitation, or alternative reimbursement models, as I think many of the payors now have momentum in
the shift of business away from hospitals. I believe that the effort by the insurance companies to direct away from the considerably
higher costs at hospitals has actually been facilitated by COVID, as most patients are reluctant, regardless of the efforts that
hospitals make to maintain safety. Most patients are reluctant to go to hospitals for elective outpatient services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I believe over a period of time, we will
continue to benefit from that as well, and conversations that I believe we&rsquo;re starting to have right after the first in the
year with payors and more interesting reimbursement models should accelerate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, thanks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Then, I know you guys talked about potentially
permanently closing some facilities. I&rsquo;m just wondering&mdash;you have about 25 that are still reopened, if we should expect
any potential closures from that, or really from some that have already reopened, or a mix shift?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. I would expect that the number of
facilities that remain closed, or somewhere in that range, could be permanent closures. Our model is a hub-and-spoke model, so
we have a lot of small satellite facilities where we do just X-ray or other routine imaging. We&rsquo;re seeing, at many of those
centers, probably, can be closed permanently and have volume absorbed in nearby centers. There&rsquo;s also some others that we
think, because the acquisitions are very close to other centers that we have, where we can probably eliminate some of those centers
also, without losing any of that volume. I would not be surprised if the number of centers that are currently closed, could remain
permanently closed as a result of this revisiting the operating model that is somewhat unique to RadNet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, no, that&rsquo;s great. Then finally,
just a quick thought that I think you mentioned, DeepHealth, they have a plan to submit their first AI product win this year. Just
curious in terms of how meaningful you think that could be for your AI initiative?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">How (inaudible)?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">How meaningful that may be to your AI initiative?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think it&rsquo;s (inaudible). Their first
product will be what we call a triage product, which will essentially take a mammogram and sort it into normal and not normal categories,
which will then allow the radiologist to prioritize his reading of the mammograms by those that are more likely to have cancers
in them, or they&rsquo;re highly suspicious of that. The more normal, which are probably about 80% of our screening mammography,
as normal, be looked at more quickly given that they have at least some indication that that exam is most likely to be normal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect efficiencies for primarily our
radiologists, and since a lot of our radiology professional fees are fixed, that could have substantial benefits to the Company.
That&rsquo;s just the first of two products, the first two products; the second one we hope to get sometime in the early part of
2021, which will actually be a diagnostic interpretation for mammography.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, thanks again for taking the questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no further questions at this
time, so I would like to turn the conference back to our hosts for any additional or closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Again, I would like to take this opportunity
to thank all of our shareholders for their continued support, and the employees of RadNet for their dedication and hard work. Management
will continue its endeavor to be a market leader that provides great services with an appropriate return on investment for all
stakeholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you for your time today, and I look
forward to our next call. I wish all of you and your families good health and safety during this unprecedented time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and gentlemen, this concludes today&rsquo;s
conference call. Thank you for your participation. You may now disconnect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !C .8# 2(  A$! Q$!_\0
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F%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rdnt-20200810.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa6A6aPty552WYkxvmRxfVkqryYqXreuly+7DPL2kVUJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:RDNT="http://radnet.com/20200810" elementFormDefault="qualified" targetNamespace="http://radnet.com/20200810">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20200810_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20200810_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>rdnt-20200810_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>rdnt-20200810_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20200810.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>radnet_i8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20200810.xsd" xlink:type="simple"/>
    <context id="From2020-08-10to2020-08-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-08-10</startDate>
            <endDate>2020-08-10</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-08-10to2020-08-10">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-08-10to2020-08-10">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="From2020-08-10to2020-08-10" id="xdx2ixbrl0010">2020-08-10</dei:DocumentPeriodEndDate>
    <dei:DocumentType contextRef="From2020-08-10to2020-08-10">8-K</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2020-08-10to2020-08-10">RADNET, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-08-10to2020-08-10">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-08-10to2020-08-10">001-33307</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-08-10to2020-08-10">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-08-10to2020-08-10">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2020-08-10to2020-08-10">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-08-10to2020-08-10">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-08-10to2020-08-10">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-08-10to2020-08-10">(310)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-08-10to2020-08-10">478-7808</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2020-08-10to2020-08-10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-08-10to2020-08-10">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-08-10to2020-08-10">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-08-10to2020-08-10">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-08-10to2020-08-10">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-08-10to2020-08-10">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-08-10to2020-08-10">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-08-10to2020-08-10">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140180206711912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 10, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 10,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RADNET,
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner
Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MNP?@_E(I>SQQN\CB1X#^WU!+ P04    " !(KPI1@ZFE ]0!   R!@  #0
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MB^$_7G\!4$L! A0#%     @ 2*\*40=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !(KPI1K65R6>X
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( $BO"E&7BKL<P    !,"   +
M      "  5T.  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( $BO"E&JQ"(6,P$
M "("   /              "  48/  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " !(KPI1)!Z;HJT   #X 0  &@              @ &F$   >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !(KPI199!YDAD!  #/
M P  $P              @ &+$0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"  #5$@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="radnet_i8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="radnet_i8k.htm">radnet_i8k.htm</File>
    <File>radnet_ex9901.htm</File>
    <File>radnet_ex9902.htm</File>
    <File>rdnt-20200810.xsd</File>
    <File>rdnt-20200810_lab.xml</File>
    <File>rdnt-20200810_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "radnet_i8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "radnet_i8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20200810_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20200810_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20200810.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20200810",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_i8k.htm",
      "contextRef": "From2020-08-10to2020-08-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://radnet.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_i8k.htm",
      "contextRef": "From2020-08-10to2020-08-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001683168-20-002615-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-20-002615-xbrl.zip
M4$L#!!0    ( $BO"E%<92^4X4   #FL @ 1    <F%D;F5T7V5X.3DP,2YH
M=&WM?6UWVDBR\'?.X3_T]4EVG7,$0>(]R>0YQ"8)>QW;:\C,SJ?G"-$8383$
MZ,6.]]??JNJ6$ AL<"P0MG9GQC9(W=5=U=7U7A^^#KZ=?2P6/GSM=D[A)\/_
M?1CT!F?=CQ_>BI_P[5OY]8=/%Z=_LO[@S[/N;T=CQ_;?,;4R\]G G'*/G?-;
M=N5,=5L1'RBLSUUS? 0OPJN7X7M3W;TV[7>L<O2Q^W-B#DV?M=ME]</;R_4/
M_L,>>K/WR4<VA>$]BP:#1V' #Y\OS@?A*(9C.>X[YO(1?/'IXX?>MR^L?W7R
MVY$YU:_Y_Z]4U/)?L^LCUCD;_'9TI8_.N<_.G&N'_>NR^X6Q$K,=YNO7S#)M
M?A0..N'F]02 :[=G/]^S6W/D3]XQK5J9_81)WL(L;Q&$CT^VIO?,YS_]DFZ9
MU_#17X'GF^.[)]^Y-;-\OKABO6_?NJ>]SJ#+KKIGW4Z_NZ^E+;V[.9TN$ 6^
M5O+,_W)X5YOY1!D2]U=\YKB^!Z\9CCUB_PYTU^=NL?#9M'7;,'4+GO "R_?2
MP'-BW8/.I[,N.^F>G5UV3D][YU]^.ZH<T=_]R\Y)^/<?O=/!U]^.U$KE]='B
M1I5\9T9C;[Y5(4BEH>/[SI3>A@T:7(4CWW#7-PW="G$&4R ;^# X#9^0!Z)2
MUNJFC2=B</KQGJ\3F!GK4].Z>\?Z=].A8\&F3,W1R/'?1]N].-Y* EH_ZD.$
MTOO8\9@.' /1S)PQ'/\?IGW-S.F4CTS=YXS_G'';XTP' C%T;\(\_0:>\-B4
MZUX +Q8+O@,#Z(8/N\/\"8>79_@7C'9R\7OOM*2VF6.SF>Z;W/;9C6,%4ZXP
M28-CTS:]"1_1FW\+"@0NXT\ +)IOJ%M C B(P0$F .Y5J\9@>98)HP)8Q<*M
M[K' 'KGZK8TSF4#2K]1JLUR/'G,Y3(MP$V]#T S@DJ;_X6WOX\).OQU<X7^0
M% ^9*E>02<2[UY'J1N]DCGXE&4V !%Q><H!8@9::3:)EH"BUHK&Q;IB6"=3G
M ?^= LO371B<&9;C<:">(3?TP.-Q>LW)XM#)XM)U##X*7+C#!,/Q@$1N.-"(
M'[A((L"K]-G,=7Z";.1S((=VY362P RH*"2#8F$&S&BDWX5C*&SL.E/@3)9S
MRV:.">S,M(')C$J=&= 4OJ^U$L.PI5%RZCITZOKLN/'[2J';45^\24/LPTW'
M;[@=<#;B<.GHQ'.JM;+Z&FGPE=JNE!O1/074A.-Z0B +KT,DJXI6$<3W2FN!
MEK')&SD?.WQ*ZXQP&.!7W4^]P6GG0__[Y<=C]<V'M_C+G*)8K5EN"(+2M#D]
M%0N;$%2MNBD]L9R@G@U!C4PKP)\@!7ET0WD3W>4,9>E7QY6RVGBSFA:*!4D]
M"G&\<#B4Q4%[^%GBXS$W\).A[ID>(%&P2MNQ2R3/&Q/=ON;AV&/==-F-;@4D
M?^E(?S ']WSFHO8!BL$UIXD,![0*D-E)-R@60NBY[MJDCLQ7 ..\ O@E=>,D
M<#<#%'?P[#]<[^_ >>\MTW=.UP=/U]?7+K]&FIDE1;\8GZR6FZ_INO;T*2\9
M',DM]DJQL/*=VNLY->57[?.DH'XP]/C? =HHX!X-T<OM462K0++YZEC.M6DH
MK&<;9?C$=@(;:(?IQ0*R*)=/N.V9H&D8CF7I0U V?;Q68403OG7@BR&2E<\,
MM&JX\,,%!F?:AA60<0,IS'!*(Y 9+6<V16B PCJ IK%))KD>4"Q<U=<<C2*^
MXUBPB)'NZR7D?C!"L4#"J,V"V;6KCX@?"O@CYC>V.*=AY6* 2J93!YZ>3>Y8
M8*/]!. U M^'\4K(@D%Q-B8V/GWW,*&O-F"*_Q+VM[)E]B([82]U(_.'3Q_/
M+OJL<_ZE>];M*^P$'H +S#9UA76":W@,IE**!1*>_F&/X#Y[+S=7$L3Q>:=_
MVOGW.W9U>CYXHZ#AE*VRT0\MW?AQ]%%G-M$'X-7B@"P7[T4D$Y.(86)>3TI
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M5I!Y#Y<N#3MBO7+PA&5':/ H/<Y\<VK2Z0'N'?AL'+@ ESO?:MTC0%&<Q,T
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M%B=V;%PMVE$<M*:8M@<J"1Y!0UR\L%7<FZ%J/*& %491*C.0^,6E'T&05%1
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M@>'@,CE91E]SD4C[%P^S:D7=#\&5J12#>',>1 T W0CX,68?0!UY&$Z^=IG
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MMKU_E[;]?+?56SH#=5&)P';J*:S@H>)X!R"OE',29PO,*^_,6HA-$Z8;EW=
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M+NVEY;MVS$_-S.>/.28<:%",![+=+U3;-I;J"Y)&Y:W!7(1<,'6([5CJ'SM
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M<CZE87__ZIG%ZUB3RU$4);G@=/_XZ6BV,3Z.][<ED7I\K@S@Z:-GLQ-%!'?
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M =D"(NMFZ(*0I7Y/)-F%N@H> 8EZ]_WC+&I3_#UU9/?VJ6)I1AV9@D\5:K9
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M:S?6Z22AO[HB)WE*667T'-Y]LPI&2XT:WY*&_F7YE:*_=NP.9263EDIC>T\
M-_:>E*,Q!3.:_J.,_YOTN.Q [9\@!L3<T9GC&2/6O!R>OC</);@"'P4S:%73
MCSQ:[QH>B(B)2)#%Z5JZ.++!T((?6W_>'K/0;,*M'RS8U-%60SUXVS/MR2#7
M]4;L[.K+4@1=C?.K8!^3:P I5/,V"XRL;UK+4+*D-JYX?:-[Z;N-V?"+Q,/\
M*;J6H;TI'&=%#5C;;64MX2ZB ?L+3 #!2]X3JVIWX[N0@X13'(SVT"TF(@=B
M-HR4"JIX?^4@T,G&?%_VLQAY$V@]WL6>X1Q;0MP2B/'4!YK+=JM*!#W,]29D
M.\0;JD/A@CY7,JIKRO9F436EZRFF!L.R1I5;.NMBXEL,4+* 6NS7U,9%"1D!
MI0=:"C#ZI6<DM)_2Z39MJ(_M-B+VT)4,8#3@3:2RPL8@)R_%3CPSN:HFX!4>
MY[CC(.L4^A)W9PQ3$TPBXH<R(T5_&$YSD#F$_I>[%OH=LO?1#CUXG9P02R7'
M(X.;+H181"YE+/:YL;U?A&EQS&_H:)[1D+B$8[%DML_[T<GT^SBB+(RETIQO
MZI+?0",P(EWW11-\9-[UH6M,-]#+CWQH=C!$8L7@ ]V<<(1^#.&NH +Q$1H>
M^@^9'7&29>/_)QY:\29W**QRHW83MUA],UFNQ3I _)JA]VW) Z5ZZ,QS7<D'
M8@DN!'W8CK*J#-;=NEQZ5@59E J;([2U:&.G+-U(;+\,)](A]<BWCOBN6Q8L
MD!,J2=MCIQN1 RT'V=3R_<U&7ZL8D^2KXLN!C-RJ0%C^V ]>S!4QT]RF\Q3^
M(!$UP[=/E)",-4Q2B(7F6QBZS"+'R6A\"Z:1P2T'9!=0]Z'M8<QTQ\H[1=G&
MSF:)26T!<-R>Z#/\/2!HL=6QT+);N7!*(.\AO262S):Z9>62*J4P^.GDVB1&
MT1@M[+)U[BA4(H:9UIA_&%PP2@!!PLC\Z*'AB[;T$89D #W]V&Z,1#0V([&,
MY<P528OM\A 4:)WO>D$>F/N/ B&)9=@C^="![/:[M_P6R>K'=\GJ3Y"L?GR7
MK/Y\M]6X._&^W9$DG>6\ER-!NTY8U1LL,#'D *J" ;&LY-PC?_-Q2EUK/07I
M)*ESN(N-448/*1J6//;6?IAY*03B=7P^0$]D/%F$XDOV;0S-6O)D*LI\5<LQ
M62[D95VP3N1LU>K<,G 7*C1=+_<9K1[]R6U*RA:M%[V- []0W/M>J_'.ZQ'2
M<K8_ 1R5GI<1+,I^IO\*A^P>5]),$U#6M2_A5U.B/:-=8Q>UIDKSJV+8Z)/A
MI\MH2G*RFL&N-H'_R@[+L3J84W5D0V,Y$#N@I21R)M=2+V&.S.<3WRRZ?-<)
MX&.+E5GB/?D0 .<:,56::?H,K8%WF^U:^8AJNF[Y1EVBQGJWN\JEY+>)A'J:
M+'6);V6FUV1G4GA.QY#931D!<CQ:FR!6?P)K9WROKD6$%@IKA^LGEI4C?I0'
MU+PQFR\T!%>G[3OFPA:HYUP,UHE1A@6CD120<F7(5^JL[?><M">$&(DQ6,$$
M5V;,TG6!05+YI>=.G!3YN>\LU')4N9S6ZEH,S"OK=RDG[K*_XAJQ!64*R52>
MB;S/1U\!8S?TL]?KDW9TE=,Z'M1:'<%SKP;.2,)IF 6/@\50(IBHYK8MIES;
M5KZGK[8]Z9V7-B]K[R-AO_LP/IMWFI^@0^R[V/CR%G$^D)V;+AM]"Q\/DC.[
M<%M9/!1_5*"3H/OK%1G91W%8H-,$79RUJ[::,LQCQUMSS?)%VUB* V:#+-K"
MXAWHFS%LY%P"O$=;.FHS#!D/JYW[9N48!$4%B:L9?D2QCWHY*I][02LLL?&P
M(XPI?]&.ET,I#A1[ 1-LX7$?G@Z^0#E=LPW4\&QMP7>=G2MJFF+L.KK@VCLR
M;MPX@T9S:V(Y;.4YA<_U)R*?!8GWVR.5] T(8FL#X-L%X4X9$] 0>0%>Y0>O
M_C8T[;#AN+]U=3ET\KN@T<+ -8R++HD:JHLNH6R2_@J!"F:[KYID'?($LHQB
MUU9.>F;/>E84:34^HH;M2F[0(]4" A[=8AM+OM.6WNNIGU#/V'P(F7KYT _.
M;3%H:-*RMJ!)WAF,+YUN$5,"0P[F"'V-\[ TA,!^%'3F&\VARPSS]:+76),$
M^I5-R3/,%RVE4^Z#KQ:AB:T@TVBHAEMLFN>B4H]\"24 349];S7,'FET(+/^
MUH+1LPC\1U0$+42]_(I7U6$NCF0.Y7\=2QV2;I0>2W$@,_+5BS I!PB$.,Z^
M%TO&SH@5DC\PMF992>MM.KEBD,TG[//N@QQF7@!F5A%"H"@ZB1)NT'6:*,A;
M;58L0K&C'A5C<[O&;SZXW3:':\9WF!('$45 LHF_(>=FR\O%-K77*/P&&WFG
M?,)]S(^QV%&;SC;+I;7:%M'EE38^+0=;*!MQ2,H=9V]AC+,YUDP_(!F]?C2*
MFOQ7Q^3?EHXCM@7F%79L:*2E+V<"'4_)ZS1S3^=3AX2;_8,/17'[Z0G5MRDB
M03_5>%Q?M# [+O):UD*,6[6-_PHT+FCGC[-WNNXKF4\P81W(_(A"V?OPP]$K
MWP&AL6H:@+?9UD)^&G:=Q]O7,"&-4)NI$P(2:=4B:  K!Y>#\3ND]1(N7'E&
MDGH[$'$XET]VZ$X#X$;L=R$;B%KE'\-FJV%)XM,MYS2"8ZCW=TMUG\&$D&;[
M8!91&4H-V.LGHJUAYC:L.%!;W;NR/1JC\>?HGN9)W62X3W1ZEU2:RY*FHY+5
M[#Q:8@3SMIA1WH9B49 3D,T L0:/"/8XZ9X0$@A+R-H:%;/6=[ K+4KDY7U'
MOI,$>9G_ZS!$YI![M?WL*>ZO<N42(N!(FPLW(>\Z5WY1GWGGZ>_1'=>K;DVH
MPJ89514@].AZK<Q5=B*Q8U#!_(4*O]\[9714<^5?H?\/PLH'@+B%OVXT%D5/
MXMZ#QZKZE*L2_6 >/$A^<R Z[.XMOT42\<E=$O$3)!&?W"41/]]M=6&' /W!
MG #,8J9'P[5C04Z03J]-6!QPMC0&#HL&SK4&6"" 8*Y-@QV*BTE8**Y\,<Z(
MCR0]I<+#IY/ )B'#&AA65.C:L)V!^R3"%O&@49AEC[K"$UJ0' R_\= 6G9$Z
M5H+:X\('Z2#$6)>34+G=< CG)$\NFXRT.[$0SM@P(@2;29[0Z$?K@V &[E!V
MS+YZUTHFQU08B@K>^SIOQ=Y*_<?7&Y'@N#D9/B3T XI_LE=CKE-T8#[OFG9.
M*&P^JGK--R1?]KBCA?=1AT/QU2_V'(=>N[TF\'$$UR.38[)"G/?@.B2F^>W3
MRT1(.X)R'0[KQZ=QZ[]M>JUG:C[DAQ*#/F3WYN*ZUO;*GDR#>_R9"3[9"F1\
MB-0#+I.FMX'UC? 5Q77+ 'DL$#DN+]_YDJ[JPXC637R=JF&^WW/[6+6PMAW#
M/ITIF=9N%C(!3.@KBWW%4A!V@;90 \]6I$EZ37+?XIMYFJB97LZ3"OD&H[<F
MK>,-D09_1O @/@S1..2XH*DIBF!MD:Y\+R[UYTTA!_QSW".RS^9UUO542RR
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M/)W&D,K@YAH+(ISDL>>1L.3F28?EE&DH.+>^_-+\6\^\@Q>C"TK*3)12]C!
M(0^<3I0'QBY#R/_CPJ$:@GQMEJ^6HZJHS!U0W]PGK>?B,>QH6_0*DMNS? B,
M8RX[SQCE2+T-,9JTO8:1M2GK_QC*K%F!8'>E'O[,:H<X,7+#/]'5S5L$EFLT
M=%4G?R?,G+6##!J8369Y8X1"M=3"O"(Y_6-=9*C#0,&K.&2,->)K_+"NDLB+
M3,:_,P05?::WF%&HW1&]16B#4'>U:\RDM;8DY]F&5)]Y4?AL27XH>4Z_8A:=
M2FI]\VR^LW)!C3JE-':I8>6#<M?0K'NDM$/LG.4)AH/Y3!?>BEY]+Y##F.!#
M#NZ^-M75FYD.NQOXR[ISEAOR<.CIA),@>T?=2>9QJJ1:,$4T*UKDJ!7_TNJ.
MHV/XG(4((_^R'>J:<(0^>W;R1::YIARQEY53?<A"$*NRGDYD!%ZG4)_'/,R-
MK_=AHO\*8.Z-*5(5^&3<UC[\/U#I\I^:R.F\$O6<;1H30V+4=,ZY]A^#HX>$
MTZA7^7R'3+*\YM')%VCAHGV\K%N3CC! ,Z@:J7.#Z\=.JKX''M(VAY,P^511
M&'FU_\;?_F4^1AJA9)KNOVKHE,O#&*XY#BT'&M_MR+=<U<K<E=.$H(CII<8B
ML%',T!E',]M0-XY@H-B]HT(!OEI3_4D*AF OD J8 >8/$89>P"R6*?Q?9+D)
MW:/,F3?>OG 2'-,[J':S<?05*N#-^W-O# 4&/BW !L^ 94#H1Z%3V5;KHC4Z
MZJ/+\FE]7E9(;%R6K<UIB%QJP]%@Q&BW=&.QBJ@S?7*"S\@S;78!2Q!ATVA
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M^?+%VU<_?XW_^.[BS?=?_]]02P,$%     @ 2*\*4490F\;2$@  (((   X
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M7-:PJ2]AC;?8>L,P4X[)T\ESHM"6#L$&8K/!H0ZV6+WR*]+\X"FZ>"@^%]N
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M]<_VZ3X-"^I78%6Q1$G%@%Q5@>4RV[4 0=+/ U%1O,]K3W0F#9A$\[*NJN+
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M*K XH$ST"G6(2CE.3$3H,2R%EA\M'9FD;ZN6J&'=-M4Q,B%2-3MC-M0=H4O
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M$T)#-^OIZWCIZ5@6?SS?.>SX?U!+ P04    " !(KPI1G,@AL3X#  ")#
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MY"A-% :C<M^C( ]V,U2(B8J?,++&&8G5@<[4@:9_5P?ZKMQ]C5>$CI!22CK
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M9.J:H$BQ& ,!*;2H$'OEXA];>6U/!-WWHM%2NJ8#L&H"8LB"8L3N#<2DDH=
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MTRI"..F=DOFQF0VRJ\4]C$#[!1,/,+=7KKG'^(T3HC@V2J1O7T)CJ C6>?M
MUXT[X-_^NSSC?_DWW+HC_P-02P$"% ,4    " !(KPI17&4OE.%    YK (
M$0              @ $     <F%D;F5T7V5X.3DP,2YH=&U02P$"% ,4
M" !(KPI18.[4KT5+  #@>0$ $0              @ $000  <F%D;F5T7V5X
M.3DP,BYH=&U02P$"% ,4    " !(KPI11E";QM(2   @@@  #@
M    @ &$C   <F%D;F5T7VDX:RYH=&U02P$"% ,4    " !(KPI1G,@AL3X#
M  ")#   $0              @ &"GP  <F1N="TR,#(P,#@Q,"YX<V102P$"
M% ,4    " !(KPI1A]18:_T*  #?AP  %0              @ 'OH@  <F1N
M="TR,#(P,#@Q,%]L86(N>&UL4$L! A0#%     @ 2*\*4?*"/(14!P  ,%D
M !4              ( !'ZX  ')D;G0M,C R,# X,3!?<')E+GAM;%!+!08
1    !@ & '\!  "FM0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
